Back
Genmab AS Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
17
GNMSF
Genmab AS
Last Price:
202.36
Seasonality Move:
-0.77%
Sell
20
ASND
Ascendis Pharma AS
Last Price:
123.21
Seasonality Move:
20.86%
Sell
17
Genmab AS (GNMSF)
is a Sell
Is Genmab AS a Buy, Sell or Hold?
- The current Genmab AS [GNMSF] share price is $202.48. The Score for GNMSF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- GNMSF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $124.38. The Score for ASND is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $124.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing slight buying pressure.
GNMSF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -7.08 | Sell |
| Relative Strength Index (14 RSI): | 35.52 | Sell |
| Chaikin Money Flow: | -365 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (213.7 - 229.94) | Sell |
| Bollinger Bands (100): | (228.63 - 270.99) | Sell |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.98 | Sell |
| Relative Strength Index (14 RSI): | 44.33 | Sell |
| Chaikin Money Flow: | 89072 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (124.33 - 129.33) | Sell |
| Bollinger Bands (100): | (124.53 - 141.57) | Sell |
GNMSF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 215.66 | Sell |
| 20-day SMA: | 221.05 | Sell |
| 50-day SMA: | 233.37 | Sell |
| 200-day SMA: | 267.15 | Sell |
| 8-day EMA: | 212.26 | Sell |
| 20-day EMA: | 219.79 | Sell |
| 50-day EMA: | 232.09 | Sell |
| 200-day EMA: | 266.24 | Sell |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.5 | Sell |
| 20-day SMA: | 126.25 | Sell |
| 50-day SMA: | 132.55 | Sell |
| 200-day SMA: | 136.92 | Sell |
| 8-day EMA: | 124.99 | Sell |
| 20-day EMA: | 126.65 | Sell |
| 50-day EMA: | 129.84 | Sell |
| 200-day EMA: | 130.32 | Sell |
Genmab AS Earnings Growth & GNMSF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.89 per share, and an increase next year of $4.01 per share.
Genmab AS Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||